Krystal Biotech, Inc. (KRYS) › Total LiabilitiesKrystal Biotech, Inc. (KRYS) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2016: $1.89M2017: $640.0K2018: $2.89M2019: $6.11M2020: $18.76M2021: $32.72M2022: $36.22M2023: $39.71M2024: $109.46M2025: $114.23M$114.23M2016Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$114.23M+4.4%2024$109.46M+175.6%2023$39.71M+9.6%2022$36.22M+10.7%2021$32.72M+74.4%2020$18.76M+207.1%2019$6.11M+111.4%2018$2.89M+351.6%2017$640.0K-66.2%2016$1.89M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share